Citation: Pj. Munson et Rk. Singh, STATISTICAL SIGNIFICANCE OF HIERARCHICAL MULTIBODY POTENTIALS BASED ON DELAUNAY TESSELLATION AND THEIR APPLICATION IN SEQUENCE-STRUCTURE ALIGNMENT, Protein science, 6(7), 1997, pp. 1467-1481
Authors:
DIFRANCESCO V
GEETHA V
GARNIER J
MUNSON PJ
Citation: V. Difrancesco et al., FOLD RECOGNITION USING PREDICTED SECONDARY STRUCTURE SEQUENCES AND HIDDEN MARKOV-MODELS OF PROTEIN FOLDS, Proteins, 1997, pp. 123-128
Citation: V. Difrancesco et al., PROTEIN TOPOLOGY RECOGNITION FROM SECONDARY STRUCTURE SEQUENCES - APPLICATION OF THE HIDDEN MARKOV-MODELS TO THE ALPHA-CLASS PROTEINS, Journal of Molecular Biology, 267(2), 1997, pp. 446-463
Citation: V. Difrancesco et al., IMPROVING PROTEIN SECONDARY STRUCTURE PREDICTION WITH ALIGNED HOMOLOGOUS SEQUENCES, Protein science, 5(1), 1996, pp. 106-113
Authors:
MAGIAKOU MA
MASTORAKOS G
RABIN D
MARGIORIS AN
DUBBERT B
CALOGERO AE
TSIGOS C
MUNSON PJ
CHROUSOS GP
Citation: Ma. Magiakou et al., THE MATERNAL HYPOTHALAMIC-PITUITARY-ADRENAL AXIS IN THE 3RD TRIMESTEROF HUMAN-PREGNANCY, Clinical endocrinology, 44(4), 1996, pp. 419-428
Citation: Ge. Rovati et al., KINFIT-II - A NONLINEAR LEAST-SQUARES PROGRAM FOR ANALYSIS OF KINETICBINDING DATA, Molecular pharmacology, 50(1), 1996, pp. 86-95
Citation: E. Haver et al., MULTIPLE TYPES OF BINDING-SITES FOR ATRIAL-NATRIURETIC-PEPTIDE IN RATOLFACTORY-BULB MEMBRANES AND SYNAPTOSOMES, Brain research, 681(1-2), 1995, pp. 75-83
Citation: Ge. Rovati et al., KINFIT-II - A NONLINEAR LEAST-SQUARES PROGRAM FOR ANALYSIS OF KINETICBINDING DATA, British Journal of Pharmacology, 111, 1994, pp. 160000322-160000322
Citation: Rn. Porrelli et al., A MODEL FOR THE EFFECT OF ESTROGEN ANTAGONISTS ON COOPERATIVE ESTRADIOL BINDING, Journal of receptor research, 13(7), 1993, pp. 1055-1081
Authors:
COSTA T
OGINO Y
MUNSON PJ
ONARAN HO
RODBARD D
Citation: T. Costa et al., DRUG EFFICACY AT GUANINE NUCLEOTIDE-BINDING REGULATORY PROTEIN-LINKEDRECEPTORS - THERMODYNAMIC INTERPRETATION OF NEGATIVE ANTAGONISM AND OF RECEPTOR ACTIVITY IN THE ABSENCE OF LIGAND, Molecular pharmacology, 41(3), 1992, pp. 549-560